Novel Agent Set for Unique Clinical Test in Inflammatory Breast Cancer

[News]

A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer, according to a researcher at Thomas Jefferson University's Kimmel Cancer Center.

More... (http://www.medicalnewstoday.com/releases/270021.php)